Cargando…
Gene networks and expression quantitative trait loci associated with adjuvant chemotherapy response in high-grade serous ovarian cancer
BACKGROUND: A major impediment in the treatment of ovarian cancer is the relapse of chemotherapy-resistant tumors, which occurs in approximately 25% of patients. A better understanding of the biological mechanisms underlying chemotherapy resistance will improve treatment efficacy through genetic tes...
Autores principales: | Choi, Jihoon, Topouza, Danai G., Tarnouskaya, Anastasiya, Nesdoly, Sean, Koti, Madhuri, Duan, Qing Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218510/ https://www.ncbi.nlm.nih.gov/pubmed/32404140 http://dx.doi.org/10.1186/s12885-020-06922-1 |
Ejemplares similares
-
Novel MicroRNA-Regulated Transcript Networks Are Associated with Chemotherapy Response in Ovarian Cancer
por: Topouza, Danai G., et al.
Publicado: (2022) -
STING agonist therapy in combination with PD-1 immune
checkpoint blockade enhances response to carboplatin chemotherapy in high-grade serous
ovarian cancer
por: Ghaffari, Abdi, et al.
Publicado: (2018) -
STAT1‐associated intratumoural T(H)1 immunity predicts chemotherapy resistance in high‐grade serous ovarian cancer
por: Au, Katrina K, et al.
Publicado: (2016) -
The Uncertain Benefit of Adjuvant Chemotherapy in Advanced Low-Grade Serous Ovarian Cancer and the Pivotal Role of Surgical Cytoreduction
por: Johnson, Racheal Louise, et al.
Publicado: (2021) -
Comparative analysis of syngeneic mouse models of high-grade serous ovarian cancer
por: Cook, David P., et al.
Publicado: (2023)